Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Caspase-8 Fluorometric Assay Kit: Precision in Apoptosis Ana
2026-05-11
The Caspase-8 Fluorometric Assay Kit empowers rapid, quantitative apoptosis and pyroptosis research in cancer and neurodegeneration models. Streamlined protocols, robust troubleshooting, and translational insight set this tool apart for modern cell death studies.
-
Aztreonam: Applied Protocols for Gram-Negative Bacterial Res
2026-05-11
Aztreonam, a synthetic monocyclic β-lactam antibiotic, empowers researchers to dissect Gram-negative resistance mechanisms and optimize targeted antimicrobial assays. This guide translates cutting-edge epidemiological insights and real-world troubleshooting into actionable laboratory workflows.
-
BKT140 (BL-8040, TF 14016) CXCR4 Antagonist: Advancing Relia
2026-05-10
This scenario-driven article explores real laboratory challenges in tumor progression, chemotaxis inhibition, and stem cell mobilization, demonstrating how BKT140 (BL-8040, TF 14016) CXCR4 Antagonist (SKU B7833) from APExBIO delivers reproducible, data-backed solutions. Evidence-based Q&A blocks guide researchers through protocol optimization, data interpretation, and vendor selection for advanced oncology and hematopoietic assays.
-
2-NBDG for Glucose Metabolism Assays: Protocols and Insight
2026-05-09
2-NBDG empowers high-sensitivity, quantitative glucose uptake studies across cell models and disease contexts, offering unmatched versatility for metabolic research. From flow cytometry to advanced diabetes models, this fluorescent glucose analog reveals uptake kinetics and mechanistic changes with clarity and reproducibility.
-
Berberine Hydrochloride: Advanced Protocols for Metabolic Re
2026-05-09
Berberine Hydrochloride stands out as a multi-targeted research tool for metabolic disease, cancer, and inflammation models, offering precise control over AMPK signaling and cell death pathways. This guide details optimized workflows, troubleshooting insights, and cross-validated parameters, ensuring reproducibility for advanced applications.
-
Nuclear cGAS Suppresses L1 Retrotransposition via TRIM41-Med
2026-05-08
This study reveals a new nuclear function of cGAS in repressing LINE-1 (L1) retrotransposition by promoting TRIM41-mediated ubiquitination and degradation of the L1-encoded ORF2p protein. These mechanistic insights expand the known roles of cGAS in genome stability and highlight posttranslational regulation of mobile genetic elements as a potential intervention point in aging and cancer.
-
SU 5402 in Advanced Cancer and Neuronal Assays: Protocols &
2026-05-07
SU 5402 unlocks multi-pathway inhibition for cancer biology and neurovirology, enabling precise dissection of FGFR, VEGFR, and PDGFR signaling. This article delivers actionable protocols, troubleshooting, and translational use-cases grounded in the latest human neuron models and myeloma research.
-
RITA (NSC 652287): Applied Workflows in Renal Carcinoma Rese
2026-05-07
RITA (NSC 652287) revolutionizes tumor suppression studies through precision MDM2-p53 inhibition and selective cytotoxicity in renal carcinoma models. This guide distills advanced experimental protocols, troubleshooting strategies, and evidence-based enhancements to maximize reproducibility and efficacy in cancer biology research.
-
JHU-083: A 6-diazo-5-oxo-L-norleucine Precursor for Glutamin
2026-05-06
JHU-083 stands out as a selective 6-diazo-5-oxo-L-norleucine precursor that enables precise targeting of glutaminase in cerebral CD11b cells. This article delivers actionable protocols, troubleshooting insights, and translational guidance for leveraging JHU-083 in experimental cerebral malaria and neurotoxicity models.
-
CXCR4-Targeted Imaging and Therapy in Lymphoma: Theranostic
2026-05-06
This review synthesizes current progress in CXCR4-targeted imaging ligands and therapeutic strategies for lymphoma, highlighting their dual diagnostic and precision therapy potential. The study details mechanistic rationale, clinical implications, and future research directions for integrating CXCR4 antagonism into lymphoma management.
-
BX795: Selective PDK1 Inhibitor for Cancer and Immune Resear
2026-05-05
BX795 is a potent, ATP-competitive PDK1 inhibitor with low-nanomolar selectivity for TBK1 and IKKε. It robustly suppresses tumor cell growth and interferon-β production, making it an essential tool for dissecting PI3K/Akt/mTOR and innate immune pathways in vitro.
-
Mitomycin C: Antitumor Antibiotic Workflows in Cancer Resear
2026-05-05
Mitomycin C stands out as a potent antitumor antibiotic for apoptosis signaling and DNA replication inhibition workflows. Explore how APExBIO’s validated compound empowers advanced assays, combination strategies, and troubleshooting in translational cancer research.
-
ETV5 and Epigenetic Regulation in Cancer: Pan-Cancer Insight
2026-05-04
This study presents a comprehensive pan-cancer analysis of ETV5, revealing its role as a prognostic marker linked to epigenetic modification and tumor progression, with a focus on hepatocellular carcinoma. It connects aberrant ETV5 expression to unfavorable outcomes, altered drug sensitivity, and EZH2-mediated epigenetic regulation, highlighting its implications for cancer epigenetics research and targeted therapy.
-
Indole-3-pyruvic Acid: Protocols and Innovations for Researc
2026-05-04
Indole-3-pyruvic acid (IPA) enables precision in plant hormone, immune, and cancer research by serving as both a metabolic probe and a signaling modulator. This article translates the latest mechanistic findings and published workflows into actionable protocols and troubleshooting strategies for bench scientists.
-
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu
2026-05-03
Harness the analytical power of MTT for robust in vitro cell proliferation and metabolic activity assessments, as exemplified in advanced cancer research. APExBIO’s high-purity MTT delivers reproducibility and accuracy, empowering researchers to decode complex cellular responses and optimize experimental workflows.